Billy Connolly announces retirement from live performance | Culture

Billy Connolly has announced that after a half-century career in standup, music, film and television he is retiring from live performing.

The news came in an interview where the comedian also revealed he had tried medicinal cannabis to treat his Parkinson’s disease, likened Donald Trump to Adolf Hitler, and rebutted Michael Parkinson’s claim that his illness had “dulled” his brain.

“He thought I’d lost track, mentally, but I never remember what year anything was,” Connolly told the Radio Times. “I haven’t a clue. I’ve always been about going forward, not the past. Plus, we were doing the GQ event, I was Inspiration of the Year, and I blew everybody away. He should have remembered that …

“These Yorkshiremen, I don’t think they apologise much. I wasn’t disappointed, it just made my life a bit difficult. People feeling sorry for me, I don’t like that.”

The Glaswegian said reports of his serious poor health were exaggerated. However, he conceded that his touring days were behind him.

Connolly, 76, who revealed he had the degenerative condition in 2013 and had successful treatment for prostate cancer in the same year, said his illness was now manageable.

Billy Connolly on stage in the 1980s.

Billy Connolly on stage in the 1980s. Photograph: Photoshot/Getty Images

He said his wife, Pamela Stephenson Connolly, had become his nurse, and he had given up using medicinal marijuana to relieve his symptoms. “I just got bomb happy. Just stoned. It was quite pleasant, but I don’t want to do that every day,” he said.

Connolly, who lives in Florida, also discussed international politics. He has been concerned by the success of Trump, citing the US president’s election as a sign that fascism is on the rise around the world. He said Trump’s rhetoric was akin to “Hitlerian lie-telling”.

“His rise is part of an international thing,” Connolly said. “It’s happening everywhere. I think it’s called fascism. They can call it white nationalism if they like, or alt-right, but it’s that Hitlerian lie-telling.

“Mocking the press, saying they’re the enemy of the people. It’s kind of frightening. Let’s wait until his time’s up. It will happen. Let’s just hope there isn’t a world war before that.”

Brexit is a “con-job”, Connolly went on to say, adding that he is opposed to Scottish nationalism and refuses to be a flag-waver.

Connolly has been promoting his new programme, Billy Connolly’s Ultimate World Tour, a travelogue in which he gives a guided tour of Florida while reminiscing on his world-spanning adventures, from his sheer amazement at the scale of the Grand Canyon to dancing naked in Orkney.

Source link

Odor Of Burnt Cannabis Is Insufficient Evidence To Warrant A Vehicle Search – Weed News

second hand marijuana cannabis smoke

The odor of burnt marijuana emanating from a motor vehicle is not a determinative factor as to whether sufficient probable cause exists to conduct a search, according to a ruling by the Vermont Supreme Court. The possession of small quantities of marijuana is legal in the state.

Justices determined that the smell of burnt cannabis alone, absent any evidence of driver impairment, did not justify the state’s decision to seize and search the defendant’s vehicle.

The Court opined, “The seizure, aimed at immobilizing the plaintiff’s vehicle while the officer sought a search warrant, was essentially based solely on the trooper’s initial detection of the faint odor of burnt marijuana, which did not, in and of itself, create fair probability that marijuana would be found in the vehicle.”

The ruling reverses a lower court decision. The case is Zullo v. Vermont.

Source: NORMLmake a donation

Source link

Demand Protection for Cannabis Consumers at the Canadian Border

Following Canada’s decision to become the first country in North America to legalize the use and retail sale of cannabis, the US Department of Homeland Security, US Customs and Border Protection Agency published a memorandum affirming that those Canadians either involved or invested in the legal cannabis industry may be barred admission into the United States.

The agency modified their policy directive on October 9, 2018, acknowledging: “A Canadian citizen working in … the legal marijuana industry in Canada, coming to the US for reasons unrelated to the marijuana industry will generally be admissible to the United States.

However, if a traveler is found to be coming to the US for reason related to the marijuana industry, they may be deemed inadmissible.”

In response to this hard-line position, Representative Earl Blumenauer, the founder of the Congressional Cannabis Caucus, has introduced the Maintaining Appropriate Protections For Legal Entry Act (HR 7275), or The MAPLE Act for short.

This legislation provides protections for individuals whose actions are “lawful in the State, Indian Tribe, or foreign country in which the conduct occurred” or that was “subsequently made lawful under the law or regulation of such jurisdiction,” in regard to the emerging legal status of marijuana in the United States and internationally.

There have already been examples of the United State’s punitive border policy needlessly wrecking lives. In one such example, an individual received a lifetime ban from entering the United States on November 14th simply because he was an investor in a legal Canadian marijuana business.

It is crucial that the United States recognizes the rights of both our citizens and our international allies to be able to travel freely between our two nations, and to reform federal border policies to acknowledge this new reality.

You can send a message to your Representative in support of The Maple Act by clicking here. 

Tags: , , , ,

Source link

Friday, December 21, 2018 Headlines | Marijuana Today Daily News

A glass jar sits on a white background next to a metal scoop with both full of hemp seeds.

Marijuana Today Daily Headlines
Friday, December 21, 2018 | Curated by host Shea Gunther

// FDA Asserts Regulatory Authority over Cannabis Derived Products (New Cannabis Ventures)

// After huge cannabis investment, Altria buys $13B stake in vape firm Juul (Marijuana Business Daily)

// ‘Like a light beer’: Will Health Canada’s THC cap make edible pot too weak? (Yahoo Finance

Today’s headlines are brought to you by our friends over at, California’s top one stop website for legal marijuana delivery. If you live in the golden state, swing over to to see if they are active in your area. With deliveries taking place in less than an hour, it’s never been easier to get legal California marijuana delivery. And of course, if you don’t live where Eaze delivers, you can still benefit from all the useful bits of industry insight and analysis they’ve developed using their properly aggregate and anonymized sales data stream.

// Ohio green lights medical marijuana lab, clearing last hurdle to begin sales (Marijuana Business Daily)

// Teacher gets job offer rescinded after disclosing medical marijuana prescription (Fox 61)

// 164 people have applied to be Utah’s new ‘cannabis czar’ (Fox 13 Salt Lake City)

// Top Rhode Island Lawmakers Are Coming To Terms With Marijuana Legalization (Marijuana Moment)

// California marijuana industry braces for ‘another enormous burden’ from next phase of testing costs (Marijuana Business Daily)

// Canopy Growth to Enter U.S. Market with Hemp Legalization (New Cannabis Ventures)

// Marijuana panel wants roadside testing before regulated market opens (VT Digger)

Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Marco Verch/Flickr

Source link

Does teen cannabis use lead to behavior problems — or vice versa? — ScienceDaily

More youth use cannabis than smoke cigarettes in the United States. In other parts of the world, cannabis use has become almost as regular as tobacco use among adolescents and young adults.

With relaxed laws governing cannabis use in many U.S. states and localities, there is mixed and limited research on whether increasing legalization could lead to other unhealthy behaviors in addition to substance use disorders.

Now, new research led by the Annenberg Public Policy Center of the University of Pennsylvania finds that cannabis use among teens does not appear to lead to greater conduct problems or greater affiliation with other teens who smoke cannabis, associations that previous research had suggested to be possible.

Instead, it’s the other way around: It is adolescents with conduct problems or whose friends use cannabis who are more likely to gravitate toward cannabis use. And that “cascading chain of events” appears to predict cannabis use disorder as the teens become young adults, according to the study, newly published in the journal Addiction.

“Cannabis use in and of itself does not appear to lead to conduct problems or increasing attraction to peers who use cannabis,” said coauthor Dan Romer, research director of the Annenberg Public Policy Center (APPC).

The study follows a group of Philadelphia adolescents over eight years. “Previous studies have not been as able to isolate the effects of cannabis use in adolescents,” Romer added. “But because we had measurements over the entire period of adolescence, we were able to disentangle the effects of cannabis use itself from other influences.”

The Philadelphia Trajectory Study

The research uses data from the Philadelphia Trajectory Study, a six-wave study that began in 2004 with interviews of nearly 400 10- to 12-year-olds in Philadelphia. The adolescents were tested annually from 2004 to 2010, and then again in 2012 for a final two-year follow-up. The current study uses data from 364 teens from the final four waves of the study. The observational study is based on self-reports from the adolescents which were then validated by urine screening.

Ivy Defoe, the lead author and former APPC postdoctoral fellow, said, “Interestingly, the results show that not only do conduct problems such as school truancy and theft predict cannabis use, but adolescents who display conduct problems are also drawn to cannabis-using peers. These affiliations predict increases in cannabis use and, eventually, cannabis use disorder, as our results show,” added Defoe, now a postdoctoral researcher at the University of Twente, the Netherlands.

Defoe said some theories would suggest that teens with conduct problems may be using cannabis as a coping mechanism to deal with disapproval of their behavior problems and perhaps to self-medicate. The study concludes that if youth with conduct problems “use unprescribed cannabis to cope with their condition, then healthier alternative coping strategies and support should be made available.”

Concerns about cannabis

One concern about use of an illegal drug is that it will lead adolescents to socialize with deviant peer groups, such as those who sell and use illegal drugs. However, the study suggests that adolescents using cannabis are no more likely to start affiliating with peers using cannabis.

The findings do suggest that with increasing legalization, there will be greater access to cannabis and thus a greater likelihood for youth to develop cannabis use disorder. However, just as with alcohol, which is legal for adults, research conducted as part of this project suggests that less than a quarter of youthful users would develop a mild cannabis use disorder.

“Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: developmental cascading links to cannabis use disorder” is published open access in the journal Addiction.

In addition to Defoe and Romer, the coauthors are Atika Khurana, Ph.D., an APPC distinguished research fellow at the University of Oregon, and Laura M. Betancourt, Ph.D., and Hallam Hurt, M.D., of the Children’s Hospital of Philadelphia.

The research was supported by grants from the National Institute on Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The Annenberg Public Policy Center was established in 1993 to educate the public and policy makers about the media’s role in advancing public understanding of political, health, and science issues at the local, state and federal levels.

Source link

Why dog owners are giving their pets cannabis | Society

As surely as the gun displayed in act I will go off in act III, the dog in a stoner comedy will get blazed. At home, amateur animal behaviorists have long studied the effects of mind-altering drugs on their pets. Now cannabis legalization brings the promise of important new medicine for animals – burdened by many of the same limitations seen in medical marijuana for humans.

Rolo the dog with his owner Christina O’Reilly.

Rolo the dog with his owner Christina O’Reilly. Photograph: Courtesy Christina O’Reilly

Legalization’s progress across much of North America has given rise to a craze for cannabidiol (CBD), a chemical found in marijuana. The chemical doesn’t get users high, but cannabis advocates have associated it with numerous medicinal properties, only a fraction of which have been scientifically proven. Some also advocate it as a treatment for pets.

A San Francisco startup, Rowley’s Good Stuff, for instance, sells tubes of CBD-infused peanut butter for dogs. Mike O’Reilly, who helped his wife, Christina, start the company, aims to simplify this “amazingly confusing industry” with a product dogs will enjoy. It was inspired by Rolo, their giant leonberger, who suffered from a painful bone cancer during the last months of his life. “He licked it right up and all of a sudden he’d be asleep like a baby.”

Gary Richter, a veterinarian in Oakland, California, says he gets asked about treating pets with CBD every day. It has “a lot of beneficial medical properties” for dogs, he says. I’ve seen animals that have fewer seizures,” as well as improvements mitigating separation anxiety, aches and pains and gastrointestinal problems like vomiting and diarrhea. “What it doesn’t do, which is unfortunately what everyone wants it to do, is fix everything.”

As a veterinarian, Richter can’t legally recommend CBD for pets, though starting 1 January in California, he will be able to discuss it with pet owners – a subtle distinction.

Despite popular belief, Richter explains, THC – the chemical in cannabis that gets users high – is not toxic for dogs and has medical applications but must be used under medical supervision.

That doesn’t mean owners should feed dogs cannabis to amuse themselves. My last column described how eating too many edibles can be a miserable experience for humans. The same thing can happen to dogs, and because they lack the awareness of what’s happening, they can hurt themselves. While the THC itself won’t kill a dog, its follow-on effects could. Richter saw one dog aspirate on its vomit and die after it consumed THC.

Veterinarians still don’t know much about the drug’s effect on pets.

Veterinarians still don’t know much about the drug’s effect on pets. Illustration: George Wylesol

Stephen Cital, a veterinary technician who advises the CBD company Phyto Animal Health, predicts that as access improves, more of the compounds found in cannabis will be incorporated into animal treatment, paralleling growing interest in these chemicals for humans. He said cannabis has been tested on 24 species, including birds, reptiles and invertebrates.

Pet owners who are curious about CBD are still largely on their own. Few veterinarians know much about it; it’s not taught in US veterinary schools.

“As with every pharmaceutical, people should be very careful about what they’re giving their pets,” Richter said. CBD dog treats can be purchased in some pet stores and online but there’s “no oversight of the quality of these products”. They’re also expensive; for a large dog, a month’s worth of CBD can easily cost $300-$400.

Source link

Black People in Philadelphia Are Still Targeted After Pot Decriminalization

Despite the decriminalization of cannabis in Philadelphia four years ago, African-Americans in the city are still being disproportionately charged with marijuana offenses by police. The city decriminalized possession of less than 30 grams of cannabis with an ordinance passed in 2014.

But arrests for possession are still made, and purchasing marijuana is still a criminal offense. In the four years since decriminalization, Black people—who represent 44 percent of the city’s population—made up 76 percent of all arrests for marijuana possession. The defendants in 81 percent of arrests for buying cannabis were Black.

The discrepancies exist despite numerous studies that have shown that White people and Black people use cannabis at comparable rates. David Rudovsky is a civil rights attorney who has filed racial bias lawsuits against the City of Philadelphia. He said in an email to local media that the racial disparity is unjustified.

“Given the equal use of marijuana by persons of different races, the fact that 80 percent of the arrests continue to be of Black suspects cannot be justified on the grounds that more Blacks than Whites possess marijuana,” said Rudovsky.

No Explanation from Police

Captain Sekou Kinebrew of the Philadelphia Police Department said that most arrests for purchasing cannabis occur during enforcement activities or investigations targeting sellers. But he was unable to explain the racial disparity.

“We are evaluating the data, along with continual examination of our policies and practices, to determine the contributing factors for the disparity,” Kinebrew said.

Lyandra Retacco, the supervisor of the District Attorney’s Office charging unit, said that defendants charged with purchasing cannabis are “almost always” arrested during sting operations against sellers. She said that her office does not press charges against people who have only been arrested for purchasing small quantities of pot.

“If it’s a street-level hand-to-hand buy, we don’t think that’s fair,” Retacco said. She also said that “the evidence is absolutely still used [to prosecute] the dealer on the street.”

In 2016, the American Civil Liberties Union determined that statewide in Pennsylvania, Black people were 3.6 times more likely to be arrested for cannabis possession. Andy Hoover, a spokesperson for the ACLU PA, said that police cannot be trusted to correct the problem themselves.

“[They] don’t have the will to fix it,” said Hoover. “That’s why marijuana policy has to be taken out of their hands by wiping marijuana criminalization off the books.”

Tickets Instead of Arrests

Since decriminalization in Philadelphia, those caught with small amounts of cannabis are issued citations instead of being arrested. The fine for simple possession is $25, while public consumption will set an offender back $100. In 2017, police wrote more than 4,200 cannabis citations and the data collected so far for 2018 indicates that the year-end total will be similar.

But only 1 in 6 issued tickets for pot pay them, leaving more than $300,000 fines unpaid over the last two years. Mark A.R. Kleiman, an expert on cannabis policy reform, said the best solution is full legalization.

“I don’t see any good purpose to be served by punishing consuming it as opposed to selling it,” Kleiman said. “Issuing uncollected fines is bad policy. You should not issue penalties that you don’t enforce.”

Source link

Charlotte’s Web Names Former Coca-Cola Executive As Chief Growth Officer – Weed News

cbd cannabis marijuana

Charlotte’s Web Holdings, Inc. (“Charlottes Web” or the “Company“), the market leader in whole-plant hemp extract products with naturally occurring cannabidiol (“CBD”), announces that Eugenio Mendez has joined the Company in the newly formed role of Chief Growth Officer effective January 15, 2019. Mr. Mendez comes to Charlotte’s Web from the Coca-Cola Company based in Atlanta, GA, where he served as Vice-President, Global Marketing of Water, Enhanced Water and Sport Drinks – one of Coca-Cola’s fastest growing categories. Mr. Mendez led global strategy and marketing for the division which has annual sales of USD$12 billion. Mr. Mendez has also served in an advisory role to Charlotte’s Web for nearly two years. As the Company’s Chief Growth Officer, he will lead the Company’s business development, marketing and sales functions.

“We’re very excited to have Eugenio formally join our Company. Over the past sixteen months, I’ve had the opportunity to work closely with Eugenio and have been deeply impressed with his global vision and experience within the consumer-packaged goods (“CPG”) industry,” said Hess Moallem, President and CEO of Charlotte’s Web. “Eugenio’s appointment illustrates the high caliber executive talent we are attracting to support the Company’s next phase of growth. With the opportunities that exist with national retail partners and anticipated international market expansion, adding top-tier executives with multi-national corporate experience is both timely and opportunistic.”

Charlotte’s Web Chairman and co-founder Joel Stanley stated, “We enthusiastically welcome Eugenio to the executive suite. He is a natural fit for Charlotte’s Web as we continue to evolve and plan for global expansion.  As the industry’s leading brand, we will benefit greatly from his marketing experience and leadership.”

The new leadership addition is the first of several appointments that will be made in 2019 to support Charlotte’s Web’s growth and evolution to a global CPG retail brand. A CEO transition is planned in 2019 to support the Company’s continued evolution from a pioneering local market participant to the national category leader it is today.  With significantly increased access to top-tier executive talent following the recent passing of the 2018 Farm Bill and removal of hemp from the Controlled Substances Act (“CSA”), further executive leadership expansion is underway in corporate development, M&A, operations, technology and other areas.

Mr. Moallem explained: “During 2019, our evolution will include bringing on a CPG focused CEO to position the Company to dominate the future landscape of the industry. Our goal to scale the organization and prepare a platform upon which our iconic brand can be even further extended has been achieved faster than anticipated. I am proud of the rapid progress we made to prepare for this moment, including the completion of a full corporate reorganization, rebranding, scaling the business and production systems, new and pending product launches and closing a very successful initial public offering. Given where we’ve positioned the Company within the category, there could not be a more opportune time to find the highest level of talent possible to lead this organization into the future.”

Mr. Moallem joined Charlotte’s Web in 2017 to position and scale the Company to be able to meet the anticipated market demand and lead the Company through a comprehensive longform IPO process while putting in place compliance programs for CSA and FDA regulations. Mr. Moallem continues as the Company’s CEO until his successor has been appointed, a search process he and the Board of Directors will begin immediately. Following a CEO transition, Mr. Moallem will stay on with the Company in an advisory role. Mr. Moallem is relinquishing his board position to further support the pending transition.

For further information subscribe to Charlotte’s Web news.

About Charlotte‘s Web Holdings, Inc.

Charlotte’s Web Holdings, Inc. is the market leader in the production and distribution of innovative hemp-based cannabidiol (“CBD”) wellness products. Founded by the Stanley Brothers, the Company’s premium quality products start with proprietary hemp genetics that are responsibly manufactured into whole plant hemp extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Industrial hemp products are non-intoxicating. Charlotte’s Web product categories include tinctures (liquid products), capsules, topical, as well as pet products. Charlotte’s Web hemp-based whole plant extracts are sold through select distributors, brick and mortar retailers, and online through the Company’s website at The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging good farming practices, and supporting U.S. farming communities.

Charlotte’s Web is a socially conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect its employees, customers, the environment, and the communities where its employees live and where it does business, while maximizing profits and strengthening its brands. Management believes that socially oriented actions have a positive impact on the Company, its employees and its shareholders. Charlotte’s Web donates a portion of its pre-tax earnings to charitable organizations.

Shares of Charlotte’s Web trade on the Canadian Securities Exchange under the symbol “CWEB” and in the United States on the OTCQX under the symbol “CWBHF”.

Source: – as featured in the Marijuana Moment newsletter

Source link

Study: Vaporizing Flower Produces A More Intense High Than Traditional Smoking Methods

Vaping marijuana flower gets you higher than smoking it, according to a new study published in an American Medical Association journal.

To test the difference, researchers started by recruiting 17 people who’d consumed cannabis in the past year but had abstained for at least one month. Each individual participated in six sessions that lasted 8 1/2 hours — three in which they smoked marijuana flower and three in which they vaped it. There were three THC concentrations of cannabis plant for both rounds of testing: zero, 10 milligrams and 25 milligrams.

After smoking or vaping, the participants were asked to fill out questionnaires to self-report their experience, and then the researchers administered a series of physical and cognitive tests. Their blood was also subsequently analyzed.

The most obvious result was that when people smoked or vaped the THC-free control substance, it didn’t have a physical or psychological effect. But at 10 milligrams — and especially 25 milligrams — the participants got pretty stoned. They reported feeling hungry, sleepy and pleasant. Their mouths were dry. Some became anxious or paranoid. Three participants experienced adverse events, such as vomiting, after consuming the 25 milligrams of cannabis.

Most regular consumers can probably attest to experiencing at least some of these things from time to time. But what might come as a surprise is that vaporized cannabis “produced significantly greater subjective drug effects, cognitive and psychomotor impairment, and higher blood THC concentrations than the same doses of smoked cannabis,” the study authors wrote in the paper published by JAMA Network Open on Nov. 30, 2018.

In previous studies, researchers allowed participants to adjust their THC dose, which is likely why earlier results suggested that smoking got people higher than vaping. But when you hold the THC dose constant, vaping seems to be a more efficient delivery system, probably because smoking requires combustion that can deplete THC.

“Vendors and consumers of cannabis products should be aware that inhaling cannabis with a vaporizer could produce more pronounced drug effects and impairment than traditional smoking methods,” the researchers wrote.

That’s relevant information as the marijuana market continues to expand. More people are opting for vaporizers, and the study indicates that infrequent or new cannabis consumers should probably approach vaporizers with a bit more caution, start low and go slow.

Source link

Nebraska Marijuana Policy Reform Advocates Establish Campaign Committee to Support 2020 Ballot Initiative

The group, Nebraskans for Sensible Marijuana Laws, will prioritize a medical marijuana ballot initiative and is researching additional marijuana reform opportunitiesTwo Nebraska state senators, Anna Wishart and Adam Morfeld, will lead a newly formed campaign committee, Nebraskans for Sensible Marijuana Laws, for the purpose of running a 2020 ballot initiative to reform marijuana laws in Nebraska via constitutional amendment.

The committee will file its initial paperwork with the Nebraska Secretary of State on Thursday morning.

Nebraskans for Sensible Marijuana Laws will prioritize the right for Nebraskans to use marijuana for medical purposes.

“Today is the first step towards establishing a compassionate medical marijuana law for sick and suffering Nebraskans,” said Sen. Wishart, who has been the lead sponsor of medical marijuana bills in the last several legislative sessions. “Thirty-two states have already adopted effective medical marijuana laws, and Nebraska will soon be joining their ranks.”

Medical marijuana initiatives were approved by voters this year in Missouri and Utah.

“Elected officials have had their opportunity to take action and failed,” said Sen. Morfeld, who helped lead the successful 2018 Medicaid Expansion ballot initiative in Nebraska. “Patients cannot wait any longer, and it’s now time for Nebraska voters to decide this issue.”

In addition to Wishart and Morfeld serving as co-chairs, the politically diverse campaign committee includes:

  • Elizabeth Seacrest, campaign treasurer and registered Independent;
  • Dexter Schrodt, campaign committee member and registered Republican;
  • John Cartier, campaign committee member and registered Democrat; and
  • Matthew Schweich, deputy director for the Marijuana Policy Project, a leading national marijuana reform organization. Schweich has helped lead five successful marijuana-related ballot initiatives over the past two election cycles in Maine, Massachusetts, Michigan, Nevada, and Utah.

“The Marijuana Policy Project is excited to work with Nebraskans for Sensible Marijuana Laws in pursuit of marijuana policies that truly serve the interests of the people,” Schweich said. “Medical marijuana is a bipartisan issue that enjoys strong support across the country, including in conservative states like Nebraska. We are confident this campaign will be successful at the ballot box in 2020.”

The immediate next steps for Nebraskans for Sensible Marijuana Laws include forming steering committees, initiative drafting, fundraising, and conducting public opinion research.

“We are assembling steering committees to represent important groups across Nebraska, including potential medical marijuana patients and their families, public safety and criminal justice reform advocates, business leaders, and others,” Wishart said. “All will play a key role in guiding this campaign.”

While medical marijuana is its top priority, Nebraskans for Sensible Marijuana Laws will also gather statewide input over the next several months on additional areas of marijuana policy reform.

“We will be conducting research to determine the level of support for additional reforms,” Morfeld said. “We are going to put forward an initiative that enjoys strong support from Nebraskans.”

Nebraskans who are interested in the campaign are encouraged to follow the group’s Facebook page at

Tags: , , , , , ,

Source link